Does pregabalin (Lyrica) cause sexual dysfunction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Lyrica Cause Sexual Dysfunction?

Yes, pregabalin (Lyrica) can cause sexual dysfunction, including erectile dysfunction, loss of libido, and anorgasmia, and these effects are not dose-related—they can occur even at low therapeutic doses (50-100 mg/day).

Evidence from FDA Drug Label

The FDA-approved prescribing information for Lyrica explicitly lists sexual dysfunction as a documented adverse effect. In post-marketing surveillance and clinical trials, the following sexual side effects have been reported 1:

  • Anorgasmia (inability to achieve orgasm)
  • Impotence (erectile dysfunction)
  • Abnormal ejaculation
  • Gynecomastia and breast enlargement (in males)

These are classified as urogenital system adverse reactions occurring with varying frequency in clinical trials.

Clinical Research Findings

Frequency and Types of Sexual Dysfunction

The most comprehensive case series found sexual dysfunction in 41.33% of patients taking pregabalin 2. This study of 75 patients revealed:

  • Erectile dysfunction: 51.61% of those with sexual dysfunction
  • Anorgasmia: 32.26%
  • Loss of libido: 35.48%

Critical Clinical Characteristics

Sexual dysfunction from pregabalin has several important features that distinguish it from other medication-related sexual problems:

  1. Not dose-dependent: Unlike gabapentin (which typically requires ≥900 mg/day), pregabalin-induced sexual dysfunction occurs at low therapeutic doses (50-100 mg/day) 2

  2. Rapid onset: Sexual dysfunction develops within weeks of starting pregabalin 2

  3. Reversible: Discontinuation of pregabalin results in improvement of sexual dysfunction within weeks 2

  4. Affects both sexes: While erectile dysfunction is male-specific, anorgasmia and loss of libido affect both men and women 2

Comparative Evidence

A controlled study specifically examining pregabalin in neuropathic pain patients found significantly lower IIEF (International Index for Erectile Function) scores in pregabalin-treated patients compared to untreated neuropathic pain patients, particularly in erectile function, orgasmic function, and overall satisfaction 3. This demonstrates that the sexual dysfunction is attributable to pregabalin itself, not just the underlying pain condition.

Multiple case reports and series consistently document erectile dysfunction 4 and anorgasmia 5 specifically associated with pregabalin add-on therapy, with temporal relationships clearly established.

Clinical Implications and Management

Assessment Strategy

Before prescribing pregabalin, clinicians should:

  • Directly inquire about baseline sexual function using validated tools (e.g., IIEF for men)
  • Document any pre-existing sexual dysfunction
  • Inform patients that sexual side effects can occur at any dose
  • Establish that these effects are reversible with discontinuation

Monitoring During Treatment

During pregabalin therapy:

  • Proactively ask about sexual function at follow-up visits (patients often don't volunteer this information)
  • Be aware that symptoms can develop within weeks
  • Recognize that dose reduction may not eliminate the problem, as effects are not dose-dependent 2

Management Options

If sexual dysfunction develops:

  1. Consider discontinuation: This is the most definitive approach, with improvement expected within weeks 2

  2. Switch to alternative agents: Other anticonvulsants like oxcarbazepine, lamotrigine, or levetiracetam may actually improve sexual function rather than worsen it 6

  3. Weigh risk-benefit: The decision depends on the indication (neuropathic pain, fibromyalgia, anxiety, epilepsy) and availability of alternatives

Important Caveats

Pregabalin can paradoxically cause sexual disinhibition and increased libido in rare cases 7, though this is far less common than sexual dysfunction. This bidirectional effect underscores the importance of individualized monitoring.

The general medical guidelines on sexual dysfunction 8 emphasize that medications cause erectile problems in up to 25% of cases, with effects often being additive when multiple medications are used. Pregabalin fits this pattern but has the unique characteristic of causing problems even at low doses.

Quality of life consideration: Sexual dysfunction significantly impacts quality of life and relationship satisfaction. Given that pregabalin is often prescribed for chronic conditions requiring long-term treatment, the high frequency (>40%) of sexual side effects 2 makes this a clinically significant concern that should factor prominently into treatment decisions.

References

Research

Sexual Dysfunctions Induced by Pregabalin.

Clinical neuropharmacology, 2018

Research

Anorgasmia during pregabalin add-on therapy for partial seizures.

Epileptic disorders : international epilepsy journal with videotape, 2013

Research

Pregabalin-induced sexual disinhibition.

Irish journal of psychological medicine, 2020

Guideline

american association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple's problem--2003 update.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.